MDS-PAS Congress 2026 Session Evaluation - Session 2103

  • MDS-PAS Congress 2026 Session 2103 Evaluation Form

  • Plenary Session 2103

    Ataxia Therapies: What Works, What's New, and What's Next?

    February 14, 2026

    08:00 - 09:45

  • Learning Objectives:

    1. Analyze effective symptomatic and supportive therapies currently used in ataxia management
    2. Recognize the landscape of emerging treatments for ataxia through late-stage clinical trials
    3. Discuss upcoming innovative gene therapy approaches and future technologies in the development of therapies for ataxia

  • Session Evaluation

  • The session met its learning objectives
  • The content is relevant to my professional and / or scientific interests.
  • The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.
  • The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.
  • The overall session organization was satisfactory and appropriate.
  • I would recommend this session to a colleague.

  • Faculty Assessment

  • José Luiz Pedroso

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Sergio Rodriguez Quiroga

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Christopher Stephen

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.
  • The following category best describes your current major professional activity (choose one):

  • Should be Empty: